Reaction
Peripheral Embolism reporting signals
As of the last recalculation, Peripheral Embolism appears in 1,150 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is DABIGATRAN ETEXILATE MESYLATE (PRR 25.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dabigatran Etexilate Mesylate | 93 | 25.1 | 25.2 |
| Dabigatran Etexilate | 94 | 23.8 | 23.8 |
| Etonogestrel And Ethinyl Estradiol | 27 | 22.5 | 22.6 |
| Alteplase | 17 | 20.8 | 20.8 |
| Felodipine Extended-Release Tablets | 10 | 16.0 | 16.0 |
| Felodipine | 10 | 16.0 | 16.0 |
| Rivaroxaban | 115 | 11.0 | 11.0 |
| Drospirenone And Ethinyl Estradiol | 16 | 6.6 | 6.6 |
| Romiplostim | 5 | 6.0 | 6.0 |